Search Results - "Parry, J.V."

Not in the vein: ‘missed hits’, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom by Hope, V.D, Parry, J.V, Ncube, F, Hickman, M

“…Highlights • Intentional subcutaneous and intramuscular injections are rare. • 56% of those aiming to inject intravenously reported ever missing a vein. •…”
Get full text

Going into the groin : Injection into the femoral vein among people who inject drugs in three urban areas of England by Hope, V.D, Scott, J, Cullen, K.J, Parry, J.V, Ncube, F, Hickman, M

“…Highlights • 53% reported ever groin (femoral vein) injecting; 41% in preceding month. • The most common reasons were “ Can’t get a vein elsewhere ”, “discreet…”
Get full text

Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities by Hope, V.D, Hickman, M, Parry, J.V, Ncube, F

“…Abstract Background People who inject drugs (PWID) are at risk of injection site infections and injuries. The factors associated with recent symptoms of these…”
Get full text

P1284 FACTORS ASSOCIATED WITH RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION AMONG PEOPLE WHO INJECT DRUGS IN THE UNITED KINGDOM: NEW FINDINGS USING AN AVIDITY TESTING ALGORITHM by Cullen, K.J, Hope, V.D, Croxford, S, Shute, J, Ncube, F, Parry, J.V

Get full text

Factors associated with the use of cleaned needles and syringes among people who inject drugs in the UK: Who should we target to minimise the risks? by Hope, V.D, Cullen, K.J, Croxford, S, Parry, J.V, Ncube, F

Get full text

Sensitive assays for viral antibodies in saliva: an alternative to tests on serum by Parry, J V, Perry, K R, Mortimer, P P

“…Paired serum and saliva specimens were tested by conventional assays and by IgG-capture radioimmunoassays (GACRIA) and enzyme-linked immunosorbent assays…”
Get more information

Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 by Hope, V.D., McVeigh, J., Smith, J., Glass, R., Njoroge, J., Tanner, C., Parry, J.V., Ncube, F., Desai, M.

“…•One in 20 people who inject image & performance enhancing drugs (IPEDs) have hepatitis C antibodies.•Uptake of hepatitis C testing was poor; less than…”
Get full text

Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK? by Njoroge, J, Hope, V D, O'Halloran, C, Edmundson, C, Glass, R, Parry, J V, Ncube, F

“…Sustaining the impact of hepatitis B virus (HBV) vaccination on incidence and prevalence of HBV infection requires increasing and maintaining the uptake of…”
Get full text

Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey by Cullen, K. J., Hope, V. D., Croxford, S., Shute, J., Ncube, F., Parry, J.V.

“…Monitoring infections and risk in people who inject drugs (PWID) is important for informing public health responses. In 2011, a novel hepatitis C antibody…”
Get full text

Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 Subtypes by Chawla, A, Murphy, G, Donnelly, C, Booth, C.L, Johnson, M, Parry, J.V, Phillips, A, Geretti, A.M

“…A guanidine-based antibody avidity assay for the identification of recently acquired human immunodeficiency virus type 1 (HIV-1) infection was evaluated. The…”
Get full text

Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution by Craine, N., Hickman, M., Parry, J.V., Smith, J., McDonald, T., Lyons, M.

“…Background In the UK, needle and syringe programmes (NSP) are delivered via community pharmacies or substance misuse services (SMSNSP). Understanding the…”
Get full text

Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic by Gupta, S B, Murphy, G, Koenig, E, Adon, C, Beyrer, C, Celentano, D, Khawaja, S, Sifakis, F, Parry, J V, Straus, W

“…Interest in estimating HIV-1 incidence using specimens obtained as part of cross-sectional surveys has led to the development of new methods to detect recent…”
Get more information

Epidemiology of hepatitis C virus in injecting drug users in england and wales: implications for HCV drug therapy by Judd, A., Hickman, M., Stimson, G.V., Hope, V.D., Gill, O., Parry, J.V.

Get full text

Diverse HIV-1 genetic subtypes in UK by Clewley, J P, Arnold, C, Barlow, K L, Grant, P R, Parry, J V

Get more information

Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort by Simmonds, P, Beatson, D, Cuthbert, R J, Watson, H, Reynolds, B, Peutherer, J F, Parry, J V, Ludlam, C A, Steel, C M

“…Markers of immune function present before infection may determine the subsequent course of disease in HIV-infected individuals. In 1983, we measured immune…”
Get more information

Reappearance of HIV antibody in an infected, seronegative individual after treatment with highly active antiretroviral therapy by RICE, P. S, CYBULSKA, B, PARRY, J. V, ROWLAND-JONES, S, DANIELS, R. S

“…There has been increasing excitement about the ability of highly active antiretroviral therapy (HAART) to allow the immune system to regenerate specific…”
Get full text

Post-transfusion HIV infection despite donor screening: a report of three cases by Martlew, V.J., Carey, P., Tong, C.Y.William, Parry, J.V., Belda, F.J., Barlow, K.L., Chu, P., Syed, Q.

“…In August 1996, a blood donation was collected which subsequently infected three patients post-transfusion with HIV 1. The donation itself was originally…”
Get full text

Preliminary report: accurate assays for anti-HIV in urine by Connell, J A, Parry, J V, Mortimer, P P, Duncan, R J, McLean, K A, Johnson, A M, Hambling, M H, Barbara, J, Farrington, C P

“…Untreated urine specimens from 358 patients (344 attending genito-urinary medicine clinics, 14 haemophiliacs) and 353 blood donors were tested blind by a…”
Get more information

Waveguide survey by Parry, J.V.

Get full text

Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors by Flanagan, P, McAlpine, L, Ramskill, S J, Smith, A G, Eglin, R, Parry, J V, Mortimer, P P

“…A combined immunoassay for the simultaneous detection of antibodies to HIV-1/2 and HTLV-I/II (Bioelisa, Launch Diagnostics) has been evaluated to determine its…”
Get more information